Transthoracic tissue Doppler imaging of the atria: A novel method to determine the atrial fibrillation cycle length

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue 11, 2006, Pages 1202-1209

  Duytschaever, Mattias ^a   Heyse, Alex ^a   De Sutter, Johan ^a   Crijns, Harry ^b   Gillebert, Thierry ^a   Tavernier, Rene ^a   Tieleman, Robert ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atrial fibrillation; Echocardiography; Electrophysiology; Tissue Doppler imaging

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BISOPROLOL; CARVEDILOL; CIBENZOLINE; DIGOXIN; DILTIAZEM; FLECAINIDE; METOPROLOL; PROPAFENONE; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GOLD STANDARD; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HUMAN; MALE; PRIORITY JOURNAL; PULSE WAVE; RELIABILITY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED;

EID: 33750037566     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00604.x     Document Type: Article

References (30)

1. Allessie MA, Konings K, Kirchhof CJ, Wijffels M: Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 1996;77:10A-23A.
2. Duytschaever M, Mast F, Killian M, Blaauw Y, Wijffels M, Allessie M: Methods for determining the refractory period and excitable gap during persistent atrial fibrillation in the goat. Circulation 2001;104:957-962.
3. Kim M, Rodefeld R, Schuessler J, Cox L, Boineau J: Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium. Circulation 1996;94:2961-2967.
4. Ramanna H, Elvan A, Wittkampf F, de Bakker J, Hauer R, Robles de Medina E: Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation. J Am Coll Cardiol 2001;37:1403-1407.
5. Konings K, Kirchhof C, Smeets J, Wellens H, Penn O, Allessie M: High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994;89:1665-1680.
6. Boahene K, Klein G, Yee R, Sharma A, Fujimura O: Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: Importance of atrial fibrillatory cycle length. J Am Coll Cardiol 1990;16:1408-1414.
7. Stambler B, Wood M, Ellenbogen K: Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Electrophysiological determinants of enhanced conversion efficacy. Circulation 1997;96:4298-4306.
8. Sticherling C, Hsu W, Tada H, Bares A, Oral H, Pelosi F, Knight B, Strickberger S, Morady F: Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness. J Cardiovasc Electrophysiol 2002;13:151-157.
9. Fynn S, Todd D, Hobbs W, Armstrong K, Garratt C: Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation; a manifestation of atrial electrical remodelling in humans? Eur Heart J 2001;22:1822-1834.
10. Haissaguerre M, Sanders P, Hocini M, Hsu L, Shah D, Scavee C, Takahashi Y, Rotter M, Pasquie J, Garrigue S, Clementy J, Jais P: Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation 2004;109:3007-3013.
11. Holm M, Pehrson S, Ingemansson M, Sornmo L, Johansson R, Sandhall L, Sunemark M, Smideberg B, Olsson C, Olsson S: Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: Introducing, validating and illustrating a new ECG method. Cardiovasc Res 1998;38:69-81.
12. Bollmann A, Kanuru N, McTeague K, Walter P, DeLurgio D, Langberg J: Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. Am J Cardiol 1998;81:1439-1445.
13. Raine D, Langley P, Murray A, Dunuwille A, Bourke J: Surface atrial frequency analysis in patients with atrial fibrillation: A tool for evaluating the effects of intervention. J Cardiovasc Electrophysiol 2004;15:1021-1026.
14. Lind B, Nowak J, Dorph J, van der Linden J, Brodin L: Analysis of temporal requirements for myocardial tissue velocity imaging. Eur J Echocardiogr 2002;3:214-219.
15. Sutherland G, Kukulski T, Voight J, D'hooge J: Tissue Doppler echocardiography: Future developments. Echocardiography 1999;16:509-520.
16. Trambaiolo P, Salustri A, Tanga M, Tonti G, Fedele F, Palamara A: Assessment of left atrial appendage wall velocities by transesophageal tissue Doppler echocardiography: A clinical study in patients with sinus rhythm. J Am Soc Echocardiogr 2002;15:425-432.
17. Topsakal R, Eryol NK, Cicek Y, Saglam H, Seyfeli E, Abaci A, Oguzhan A, Ergin A, Basar E: Evaluation of left atrial appendage functions in patients with thrombus and spontaneous echo contrast in left atrial appendage by using color Doppler tissue imaging. Ann Noninvasive Electrocardiol 2004;9:345-351.
18. Parvathaneni L, Mahenthiran J, Jacob S, Foltz J, Gill WJ, Ghumman W, Gradus-Pizlo I, Feigenbaum H, Sawada SG: Comparison of tissue Doppler dynamics to Doppler flow in evaluating left atrial appendage function by transesophageal echocardiography. Am J Cardiol 2005;95:1011-1014.
19. Topsakal R, Eryol N, Ozdogru I, Seyfeli E, Abaci A, Oguzhan A, Basar E, Ergin A, Cetin S: Color Doppler tissue imaging to evaluate left atrial appendage function in patients with mitral stenosis in sinus rhythm. Echocardiography 2004;21:235-240.
20. Thomas L, Boyd A, Thomas S, Schiller N, Ross D: Atrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation. Eur Heart J 2003;24:1942-1951.
21. Di Salvo G, Caso P, Lo Piccolo R, Fusco A, Martiniello A, Russo M, D'Onofrio A, Severino S, Calabro P, Pacileo G, Mininni N, Calabro R: Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: A color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation 2005;112:387-395.
22. Manning W, Silverman D, Katz S, Riley M, Come P, Doherty R, Munson J, Douglas P: Impaired left atrial mechanical function after cardioversion: Relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994;23:1535-1540.
23. Schotten U, Duytschaever M, Ausma J, Eijsbouts S, Neuberger H, Allessie M: Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation 2003;107:1433-1439.
24. Mitusch R, Garbe M, Schmucker G, Schwabe K, Stierle U, Sheikhzadeh A: Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. Am J Cardiol 1995;75:944-947.
25. Lazar S, Dixit S, Marchlinski FE, Callans DJ, Gerstenfeld EP: Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. Circulation 2004;110:3181-3186.
26. Duytschaever M, Garratt C, Allessie M: Profibrillatory effects of verapamil but not of digoxin in the goat model of atrial fibrillation. J Cardiovasc Electrophysiol 2000;11:1375-1385.
27. Fujiki A, Tsuneda T, Sugao M, Mizumaki K, Inoue H: Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm. Am J Cardiol 2003;92:472-475.
28. Husser D, Stridh M, Sornmo L, Platonov P, Olsson SB, Bollmann A: Analysis of the surface electrocardiogram for monitoring and predicting antiarrhythmic drug effects in atrial fibrillation. Cardiovasc Drugs Ther 2004;18:377-386.
29. Bollmann A, Husser D, Steinert R, Stridh M, Soernmo L, Olsson S, Polywka D, Molling J, Geller C, Klein H: Echocardiographic and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol 2003;14:S162-S165.
30. Gillis A, Unterberg-Buchwald C, Schmidinger H, Massimo S, Wolfe K, Kavaney D, Otterness M, Hohnloser S: Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002;40:1653-1659.